NHS 10 years away from harnessing the benefits of genome medicineBMJ 2009; 338 doi: https://doi.org/10.1136/bmj.b278 (Published 23 January 2009) Cite this as: BMJ 2009;338:b278
- Adrian O’Dowd
The NHS in the United Kingdom is at least 10 years away from being fully ready for the changes that genomic medicine are predicted to bring, peers have been told.
Genome-wide association studies are increasingly able to identify which variations in the human genome are associated with more or less risk of disease. It is hoped that this information will allow targeted interventions—screening, drug treatment, and so on—for people at most risk.
Department of Health witnesses appeared before the House of Lords’ science and technology committee on 21 January and said that a lot of preparation is needed before the NHS is ready to start using genomic medicine to its full potential.
Growing evidence …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial